Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
34 hedge funds and large institutions have $98.8K invested in Ampio Pharmaceuticals Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
3% less funds holding
Funds holding: 35 → 34 (-1)
21% less capital invested
Capital invested by funds: $125K → $98.8K (-$25.9K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$5.86K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$3.98K |
| 3 |
Renaissance Technologies
New York
|
+$2.77K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$2.63K |
| 5 |
VF
Virtu Financial
New York
|
+$2.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$27.7K |
| 2 |
Millennium Management
New York
|
-$9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.29K |
| 4 |
Goldman Sachs
New York
|
-$3.01K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.78K |
AMPE Hedge Fund Activity: Q2 2023 in Review
34 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2023, worth a combined $98.8K — down 21% from $125K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AMPE and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.
The largest buyer was IHT Wealth Management, opening a new position worth an estimated $5.86K. The largest seller was HRT Financial, cutting an estimated $27.7K.
- 34 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2023, down from 35 in Q1 2023.
- Funds reported $98.8K of Ampio Pharmaceuticals Inc. stock for Q2 2023, down 21% quarter-over-quarter.
- 3 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2023 and 4 closed out, a net change of -1 holder.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2023 was IHT Wealth Management, an estimated $5.86K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2023 was HRT Financial, an estimated $27.7K sold.
Based on aggregated 13F filings for Q2 2023.